Detection of illegal drugs is an ongoing battle and the rapid analysis and identification of prohibited substances is critical to prevent their importation and widespread distribution. Additionally, the data generated needs to be significantly robust for submission in court cases. In most countries across the globe, a minimum of two orthogonal analytical methods must be used in drug testing to provide detailed and admissible evidence. Nuclear Magnetic Resonance and Mass Spectrometry are well established key methods for narcotics analysis, and operate on fundamentally different scientific principles, thus providing definitive identifications. Both methods validate each other and are now brought to your lab bench by Bruker. Today, Bruker’s powerful approach provides enhanced ease of use and maximized method compliance. Bruker supports leading law enforcement authorities worldwide. Become part of the community!
This webinar will be of interest to those working in forensic laboratories, law enforcement authorities, customs & border protection agencies, regulatory bodies, official control laboratories and undertaking analysis of narcotics or suspected narcotics.
Dr. Venita Decker
Product Manager FT-NMR benchtop solutions, BBIO, Bruker BioSpin, Rheinstetten, Germany
Dr. Joerg Koehler
Head of Business Unit Industrial, Bruker BioSpin, Rheinstetten, Germany
Dr. Andrea Kiehne
Head of Bremen applied solutions demo team, Bruker Daltonik, Bremen